49P - Xentuzumab: Targeting IGF1R/IR signalling in ER positive breast cancer

Autor: Losurdo, A., O'Donovan, N., Winrow, D., Gullo, G., Santoro, A., Crown, J.
Zdroj: In Annals of Oncology May 2017 28 Supplement 1:i19-i19
Databáze: ScienceDirect